» Authors » Mads Melbye

Mads Melbye

Explore the profile of Mads Melbye including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 422
Citations 17349
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Corn G, Lund M, Andersson N, Dohlmann T, Hlatky M, Wohlfahrt J, et al.
Am Heart J . 2024 May; 274:102-112. PMID: 38710378
Background: The response of low-density lipoprotein cholesterol (LDL-C) to statin therapy is variable, and may be affected by the presence of co-morbid conditions or the use of concomitant medications. Systematic...
12.
Pasternak B, Wintzell V, Hviid A, Eliasson B, Gudbjornsdottir S, Jonasson C, et al.
BMJ . 2024 Apr; 385:e078225. PMID: 38683947
Objective: To investigate whether use of glucagon-like peptide 1 (GLP1) receptor agonists is associated with increased risk of thyroid cancer. Design: Scandinavian cohort study. Setting: Denmark, Norway, and Sweden, 2007-21....
13.
Miller H, Tierney S, Stefanick M, Mayo J, Sedan O, Rosas L, et al.
Am Heart J . 2024 Mar; 272:96-105. PMID: 38484963
Background: Preeclampsia is associated with a two-fold increase in a woman's lifetime risk of developing atherosclerotic cardiovascular disease (ASCVD), but the reasons for this association are uncertain. The objective of...
14.
Bager P, Poulsen G, Wohlfahrt J, Melbye M
Allergy . 2024 Jan; 79(4):1028-1041. PMID: 38247235
Background: Because long-term effectiveness of pollen allergen immune therapy (AIT) for allergic rhinitis (AR) is not well-described, we studied effectiveness over 18 years in Denmark. Methods: A register-based cohort study...
15.
Andersson N, Corn G, Dohlmann T, Melbye M, Wohlfahrt J, Lund M
Age Ageing . 2024 Jan; 53(1). PMID: 38219226
Background: Data about the clinical benefit from initial low-density lipoprotein cholesterol (LDL-C) reduction with lipid lowering treatment for secondary prevention and risk of major vascular events amongst older as compared...
16.
Andersson N, Wohlfahrt J, Feenstra B, Hviid A, Melbye M, Lund M
Ann Intern Med . 2023 Dec; 177(1):1-11. PMID: 38109740
Background: According to drug labels, the frequency of thiazide-induced hyponatremia is unknown or uncommon to very rare (that is, <1 in 10 000 to <1 in 100), but the exact...
17.
Engstrom A, Wintzell V, Melbye M, Svanstrom H, Eliasson B, Gudbjornsdottir S, et al.
Hepatology . 2023 Dec; 79(6):1401-1411. PMID: 38085855
Background And Aims: Clinical trials suggest that glucagon-like peptide-1 (GLP-1) receptor agonists may have beneficial effects on NAFLD, but the impact on hard hepatic end points is unknown. We assessed...
18.
Moller F, Junker T, Sorensen K, Eves C, Wohlfahrt J, Dillner J, et al.
Sci Rep . 2023 Dec; 13(1):21601. PMID: 38062070
Consumer purchase data (CPD) is a promising instrument to assess the impact of purchases on health, but is limited by the need for manual scanning, a lack of access to...
19.
Lihme F, Savu A, Basit S, Sia W, Yeung R, Barrett O, et al.
Acta Obstet Gynecol Scand . 2023 Nov; 103(2):266-275. PMID: 37948551
Introduction: Preeclampsia and gestational diabetes mellitus share risk factors such as obesity and increased maternal age, which have become more prevalent in recent decades. We examined changes in the prevalence...
20.
Beaumont R, Flatley C, Vaudel M, Wu X, Chen J, Moen G, et al.
Nat Genet . 2023 Oct; 55(11):1807-1819. PMID: 37798380
A well-functioning placenta is essential for fetal and maternal health throughout pregnancy. Using placental weight as a proxy for placental growth, we report genome-wide association analyses in the fetal (n ...